ALNY

Alnylam Pharmaceuticals, Inc. News Headlines

$100.73
*  
1.32
1.33%
Get ALNY Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading ALNY now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ALNY Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Good News for Alnylam - Analyst Blog
8/19/2013 6:10:01 PM - Zacks.com


Narrower-than-Expected Q2 Loss at Alnylam - Analyst Blog
8/14/2013 8:35:01 AM - Zacks.com


Aegerion's Lojuxta Gets EU Approval - Analyst Blog
8/5/2013 4:20:01 PM - Zacks.com


Best Stocks: Isis, Gilead, Celgene, and Regeneron Take Over the Top Ranks
7/29/2013 8:20:00 AM - Minyanville


Alnylam Targets New Highs On Data Supporting RNAi
7/19/2013 6:14:00 PM - Seeking Alpha


Putting Alnylam's Positive ATTR Clinical Data In Context
7/19/2013 1:28:00 PM - Seeking Alpha


Market Wrap for Friday, July 12: Stocks Rise as S&P 500 Closes At New All-Time High
7/12/2013 3:45:17 PM - Benzinga


A Great Day And A Great Future For Alnylam
7/12/2013 11:45:00 AM - Seeking Alpha


Northera NDA Resubmitted By Chelsea - Analyst Blog
7/11/2013 5:56:18 PM - Zacks.com


Market Wrap for Thursday, July 11: Market Jumps on Dovish Bernanke Comments
7/11/2013 3:14:45 PM - Benzinga


Australian Approval for Vertex' Kalydeco - Analyst Blog
7/10/2013 10:40:01 AM - Zacks.com


BioMarin Files Vimizim MA in Brazil - Analyst Blog
7/5/2013 3:20:01 PM - Zacks.com


Positive Data on Alnylam's Candidate - Analyst Blog
7/1/2013 5:37:43 PM - Zacks.com


Celgene Inks Oncology Deal - Analyst Blog
6/27/2013 10:31:58 AM - Zacks.com


Celgene presents Revlimid Data - Analyst Blog
6/26/2013 10:30:01 AM - Zacks.com


Gilead Retained at Neutral - Analyst Blog
6/25/2013 10:31:22 AM - Zacks.com


When Alnylam Reports ALN-TTR02 Results, Investors Should Look At Tekmira A Second Time
6/24/2013 12:28:00 PM - Seeking Alpha


2 Biotechs With Recent Intensive Insider Selling
6/16/2013 3:00:00 AM - Seeking Alpha


Tekmira Pharmaceuticals: An Interesting Long-Term Investment
6/13/2013 2:02:00 PM - Seeking Alpha


Cramer's Lightning Round - The All-Clear For Allstate (6/6/13)
6/7/2013 7:30:00 AM - Seeking Alpha


3 Pharmaceuticals With Strong Potential
6/5/2013 6:32:00 AM - Seeking Alpha


CHMP Positive on Aegerion's Lojuxta - Analyst Blog
6/3/2013 4:25:58 PM - Zacks.com


Alnylam Narrows Loss, Sales Fall - Analyst Blog
5/7/2013 8:25:01 AM - Zacks.com


Pipeline Progresses at ViroPharma - Analyst Blog
4/23/2013 5:11:00 PM - Zacks.com


The Beginning Of A Shift At Tekmira: From Focus On Delivery, To Therapy
4/23/2013 11:53:00 AM - Seeking Alpha